Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
South Asian Journal of Cancer|June 16, 2021
Chemotherapy-Induced Nausea and Vomiting (CINV) with GI Cancer Chemotherapy: Do We Need CINV Risk Score Over and Above Antiemetic Guidelines in Prescribing Antiemetic Regime?Anita D'Souza, Dipalee Pawar, Anant Ramaswamy, et al.Oral Oncology|December 13, 2016
Expectations and preferences for palliative chemotherapy in head and neck cancers patientsVijay Patil, Amit Joshi, Vanita Noronha, et al.South Asian Journal of Cancer|November 16, 2018
Quality of life and quality-adjusted time without toxicity in palliatively treated head-and-neck cancer patientsVijay Patil, Amit Joshi, Vanita Noronha, et al.Oral Oncology|December 12, 2017
Results of a phase II randomized controlled clinical trial comparing efficacy of Cabazitaxel versus Docetaxel as second line or above therapy in recurrent head and neck cancerAmit Joshi, Vijay Patil, Vanita Noronha, et al.Journal of Global Oncology|September 23, 2018
Distress Management in Patients With Head and Neck Cancer Before Start of Palliative Chemotherapy: A Practical ApproachVijay Patil, Vanita Noronha, Amit Joshi, et al.Indian Journal of Critical Care Medicine : Peer-Reviewed, Official Publication of Indian Society of Critical Care Medicine|September 14, 2019
Indian Antimicrobial Prescription Guidelines in Critically Ill Immunocompromised PatientsAtul P Kulkarni, Manju Sengar, Girish Chinnaswamy, et al.Frontiers in Oncology|September 27, 2021
Demographics, Pattern of Care, and Outcome Analysis of Malignant Melanomas - Experience From a Tertiary Cancer Centre in IndiaJyoti Bajpai, George Abraham, Avanish P Saklani, et al.Cancer Letters|April 10, 2025
Phase 3 randomized study of physician choice vs metronomic chemotherapy in platinum refractory/ineligible head and neck cancer in palliative setting with survival outcomesRushabh Kothari, Vijay Patil, Ravi Krishna Madala, et al.Cancer|June 1, 2019
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancerVijay Maruti Patil, Vanita Noronha, Amit Joshi, et al.Pageof 1